This public procurement contract aims to select a supplier for the delivery of pharmaceutical products listed in Appendix No. 2 of the Positive Drug List, specifically for the needs of Popovo Hospital. The contract will involve periodic deliveries of these products under the most favorable condition
Contract awarded. Originally published 1 years ago.
Only 2 prior awards here — too little to read.
In healthcare medical, MULTIPURPOSE HOSPITAL FOR ACTIVE TREATMENT - POPOVO EOOD has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This public procurement contract aims to select a supplier for the delivery of medical devices for the surgical and orthopedic department of the Multi-Profile Hospital for Active Treatment - Popovo EOOD. The contract will cover periodic deliveries of medical supplies as specified in the attached tec
This public procurement contract aims to select a supplier for the delivery of medical devices for the surgical and orthopedic department of the Multi-Profile Hospital for Active Treatment - Popovo EOOD. The contract includes periodic deliveries of medical supplies as specified in the attached techn
This public procurement contract aims to select a supplier for the delivery of pharmaceutical products listed in Appendix No. 2 of the Positive Drug List for the needs of the Multi-Profile Hospital for Active Treatment - Popovo EOOD. The contract will involve periodic deliveries of these products un
NHS Scotland is seeking suppliers of generic and biosimilar cancer medicines to improve patient access and optimize healthcare costs.
Royal Borough of Greenwich is commissioning a School Health and Wellbeing Service to deliver preventative health and early intervention support for children and young people aged 5-19 years across the borough, with contract commencement in April 2027.
Suffolk County Council is testing market interest for postal delivery of nicotine replacement therapy and smoking cessation medications to improve accessibility for local residents.
PSD Scotland is engaging with the market to explore delivery solutions for a national Targeted Lung Cancer Screening Programme for smokers aged 55-74 in Scotland.
